{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:49:50Z","timestamp":1794718190727,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG081932"],"award-info":[{"award-number":["R01AG081932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS127344"],"award-info":[{"award-number":["R01 NS127344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS124084"],"award-info":[{"award-number":["R01 NS124084"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG071515"],"award-info":[{"award-number":["R01AG071515"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.expneurol.2025.115461","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:51:54Z","timestamp":1757659914000},"page":"115461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's disease"],"prefix":"10.1016","volume":"394","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Kakazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmane","family":"Surasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gerochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 12","key":"10.1016\/j.expneurol.2025.115461_bb0005","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington\u2019s disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115461_bb0010","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"16","key":"10.1016\/j.expneurol.2025.115461_bb0015","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1016\/j.jmb.2020.06.021","article-title":"Protofilament structure and supramolecular polymorphism of aggregated mutant huntingtin exon 1","volume":"432","author":"Boatz","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115461_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00695604","article-title":"Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema","volume":"64","author":"Bothe","year":"1984","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2025.115461_bb0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115461_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115461_bb0035","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1364\/BOE.6.003941","article-title":"Cerebral metabolic rate of oxygen (CMRO2) assessed by combined doppler and spectroscopic OCT","volume":"6","author":"Chong","year":"2015","journal-title":"Biomed. Opt. Express"},{"issue":"2","key":"10.1016\/j.expneurol.2025.115461_bb0040","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J. Nucl. Med."},{"issue":"Pt 11","key":"10.1016\/j.expneurol.2025.115461_bb0045","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"issue":"25","key":"10.1016\/j.expneurol.2025.115461_bb0050","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1021\/acs.biochem.5b00281","article-title":"Solid-state nuclear magnetic resonance on the static and dynamic domains of huntingtin Exon-1 fibrils","volume":"54","author":"Isas","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2025.115461_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.769184","article-title":"Molecular strategies to target protein aggregation in Huntington\u2019s disease","volume":"8","author":"Jarosinska","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115461_bb0060","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.expneurol.2025.115461_bb0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0271678X20949286","article-title":"Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington\u2019s disease","volume":"41","author":"Klinkmueller","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"13","key":"10.1016\/j.expneurol.2025.115461_bb0070","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1093\/hmg\/ddy141","article-title":"Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin","volume":"27","author":"Ko","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.expneurol.2025.115461_bb0075","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","article-title":"Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation","volume":"107","author":"Lee","year":"2020","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.expneurol.2025.115461_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4207","article-title":"Quantitative theory for the transverse relaxation time of blood water","volume":"33","author":"Li","year":"2020","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115461_bb0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbadis.2009.06.008","article-title":"Impaired mitochondrial trafficking in Huntington\u2019s disease","volume":"1802","author":"Li","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.expneurol.2025.115461_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10334-011-0287-2","article-title":"Blood longitudinal (T1) and transverse (T2) relaxation time constants at 11.7 tesla","volume":"25","author":"Lin","year":"2012","journal-title":"MAGMA"},{"key":"10.1016\/j.expneurol.2025.115461_bb0095","doi-asserted-by":"crossref","first-page":"15462","DOI":"10.1038\/ncomms15462","article-title":"Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115461_bb0100","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/brain\/awab190","article-title":"Huntingtin silencing delays onset and slows progression of Huntington\u2019s disease: a biomarker study","volume":"144","author":"Liu","year":"2021","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.expneurol.2025.115461_bb0105","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","article-title":"Striatal hypometabolism in premanifest and manifest Huntington\u2019s disease patients","volume":"43","author":"Lopez-Mora","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.expneurol.2025.115461_bb0110","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington\u2019s disease for translation to the clinic: best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115461_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115461_bb0120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.25009","article-title":"Abnormal response to cortical activation in early stages of Huntington disease","volume":"27","author":"Mochel","year":"2012","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115461_bb0125","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/mrm.27823","article-title":"Volume-localized measurement of oxygen extraction fraction in the brain using MRI","volume":"82","author":"O\u2019Brien","year":"2019","journal-title":"Magn. Reson. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115461_bb0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.expneurol.2008.12.015","article-title":"Functional imaging in Huntington\u2019s disease","volume":"216","author":"Paulsen","year":"2009","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115461_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148839","article-title":"Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 Knock-in mouse model of Huntington\u2019s disease","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"issue":"4\u20135","key":"10.1016\/j.expneurol.2025.115461_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brainresbull.2009.07.010","article-title":"Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease","volume":"80","author":"Quintanilla","year":"2009","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115461_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","article-title":"Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington\u2019s disease","volume":"1822","author":"Reddy","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"574","key":"10.1016\/j.expneurol.2025.115461_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc2888","article-title":"Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington\u2019s disease","volume":"12","author":"Rodrigues","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115461_bb0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2025.115461_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/B978-0-12-801893-4.00020-1","article-title":"Structural imaging in premanifest and manifest Huntington disease","volume":"144","author":"Scahill","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.expneurol.2025.115461_bb0165","first-page":"5","article-title":"Control of the structural landscape and neuronal proteotoxicity of mutant huntingtin by domains flanking the polyQ tract","author":"Shen","year":"2016","journal-title":"Elife"},{"issue":"17","key":"10.1016\/j.expneurol.2025.115461_bb0170","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","article-title":"An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes","volume":"25","author":"Southwell","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.expneurol.2025.115461_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13080961","article-title":"The urine metabolome of R6\/2 and zQ175DN Huntington\u2019s disease mouse models","volume":"13","author":"Speziale","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.expneurol.2025.115461_bb0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.expneurol.2025.115461_bb0185","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","article-title":"Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease","volume":"123","author":"Tang","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.expneurol.2025.115461_bb0190","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/jcbfm.2012.104","article-title":"Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease","volume":"32","author":"Tkac","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115461_bb0195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00004647-199907000-00012","article-title":"In vivo determination of absolute cerebral blood volume using hemoglobin as a natural contrast agent: an MRI study using altered arterial carbon dioxide tension","volume":"19","author":"Ulatowski","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.expneurol.2025.115461_bb0200","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.25010","article-title":"Brain metabolite alterations and cognitive dysfunction in early Huntington\u2019s disease","volume":"27","author":"Unschuld","year":"2012","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115461_bb0205","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s00415-011-6099-5","article-title":"Exploratory 7-tesla magnetic resonance spectroscopy in Huntington\u2019s disease provides in vivo evidence for impaired energy metabolism","volume":"258","author":"van den Bogaard","year":"2011","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2025.115461_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70055","article-title":"Evolution of aberrant brain-wide spatiotemporal dynamics of resting-state networks in a Huntington\u2019s disease mouse model","volume":"14","author":"Vasilkovska","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115461_bb0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12929-024-01028-3","article-title":"Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington\u2019s disease","volume":"31","author":"Vasilkovska","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.expneurol.2025.115461_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106438","article-title":"Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington\u2019s disease","volume":"193","author":"Vidas-Guscic","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115461_bb0225","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1007\/s00415-024-12700-x","article-title":"A 14-year longitudinal study of neurofilament light chain dynamics in premanifest and transitional Huntington\u2019s disease","volume":"271","author":"Voysey","year":"2024","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.expneurol.2025.115461_bb0230","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jmb.2018.03.017","article-title":"Self-assembly of mutant huntingtin Exon-1 fragments into large complex fibrillar structures involves nucleated branching","volume":"430","author":"Wagner","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2025.115461_bb0235","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mrm.27046","article-title":"Quantitative assessment of cerebral venous blood T(2) in mouse at 11.7T: implementation, optimization, and age effect","volume":"80","author":"Wei","year":"2018","journal-title":"Magn. Reson. Med."},{"issue":"4","key":"10.1016\/j.expneurol.2025.115461_bb0240","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/mrm.27592","article-title":"Optimization of phase-contrast MRI for the estimation of global cerebral blood flow of mice at 11.7T","volume":"81","author":"Wei","year":"2019","journal-title":"Magn. Reson. Med."},{"issue":"9","key":"10.1016\/j.expneurol.2025.115461_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4568","article-title":"Brain metabolism in tau and amyloid mouse models of Alzheimer\u2019s disease: an MRI study","volume":"34","author":"Wei","year":"2021","journal-title":"NMR Biomed."},{"issue":"23","key":"10.1016\/j.expneurol.2025.115461_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314763","article-title":"A novel Huntington\u2019s disease assessment platform to support future drug discovery and development","volume":"23","author":"Wu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2025.115461_bb0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.21994","article-title":"Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI","volume":"62","author":"Xu","year":"2009","journal-title":"Magn. Reson. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115461_bb0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","article-title":"PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline","volume":"20","author":"Young","year":"1986","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2025.115461_bb0265","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","article-title":"Cortical metabolites as biomarkers in the R6\/2 model of Huntington\u2019s disease","volume":"32","author":"Zacharoff","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625003267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625003267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:28:43Z","timestamp":1780201723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625003267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S0014488625003267"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115461","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.16.643551","asserted-by":"object"}]},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115461"}}